WP4: Biobank Assessment
Lead
Helsinki University
Institute for Molecular Medicine Finland FIMM & Department of Public Health
Prof. Jaakko Kaprio
King’s College London
Institute of Psychiatry, Psychology & Neurosciences
Prof. Allan Young and Dr. Mario Juruena
Participants/Support
- Tel Aviv University
- King’s College London
Goals
- Big data will be obtained from Finnish and UK genetic databases to assess pharmacogenetic genotype and clinical outcomes in patients with mood-, anxiety or psychotic disorders to investigate real-world, large-scale and long-term perspectives on outcomes of specific disease – medication stratified by CYP2C19 and CYP2D6 genotype.